The role of proteomics in dementia and Alzheimer’s disease

2009/03/03 by Maria Zellner, Michael Veitinger, Ellen Umlauf · 14 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Advanced Proteomics Techniques and Applications #Alzheimer's disease #Alzheimer's disease research and treatments #Bioinformatics #Biology #Computational biology #Dementia #Disease #Gene #Genetics #Laser capture microdissection #Medicine #Metabolomics and Mass Spectrometry Studies #Pathology #Proteome #Proteomics #Quantitative proteomics

paper · doi:10.1007/s00401-009-0502-7

openalex publication_date 2009/03/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Cited by

• Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease. [europepmc]
• Responses of HSC70 expression in diencephalon to iron deficiency anemia in rats. [europepmc]
• Biomarkers of basic activities of daily living in Alzheimer's disease. [europepmc]
• Cystatin C in Alzheimer's disease. [europepmc]
• Plasma proteomics for the identification of Alzheimer disease. [europepmc]
• Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. [europepmc]
• Recent advances in quantitative neuroproteomics. [europepmc]
• Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer's disease and age-matched control brains. [europepmc]
• Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates. [europepmc]
• Proteomic analysis of laser capture microscopy purified myotendinous junction regions from muscle sections. [europepmc]
• A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype. [europepmc]
• Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementia. [europepmc]
• Cystatin C in aging and in Alzheimer's disease. [europepmc]
• Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks. [europepmc]